Zhenyu Yan

机构：North China University of Science and Technology Affiliated Hospital · ORCID：0000-0003-4972-0095

发表论文 60 篇 · 总被引 1214 次 · h-index 9

代表论文

• Efficacy and safety of sovleplenib (HMPL-523) in adult patients with chronic primary immune thrombocytopenia in China (ESLIM-01): a randomised, double-blind, placebo-controlled, phase 3 study (2024 · The Lancet Haematology · 被引 29)
• The immunological role of mesenchymal stromal cells in patients with myelodysplastic syndrome (2022 · Frontiers in Immunology · 被引 17)
• Factor IX-Padua AAV gene therapy in hemophilia B: phases 1/2 and 3 trials (2025 · Nature Medicine · 被引 9)
• Effects of orelabrutinib, a BTK inhibitor, on antibody‐mediated platelet destruction in primary immune thrombocytopenia (2025 · British Journal of Haematology · 被引 5)
• A Novel Next-Generation Sequencing Assay for the Identification of BCR :: ABL1 Transcript Type and Accurate and Sensitive Detection of TKI-Resistant Mutations (2024 · The Journal of Applied Laboratory Medicine · 被引 5)
• Dose-optimised recombinant human thrombopoietin versus eltrombopag in patients with immune thrombocytopenia: a multicenter, randomised controlled trial (The TE-ITP Study) (2025 · EClinicalMedicine · 被引 4)